Clinical Trials Logo

Pathologic Fracture clinical trials

View clinical trials related to Pathologic Fracture.

Filter by:
  • None
  • Page 1

NCT ID: NCT05825456 Recruiting - Metastatic Cancer Clinical Trials

Metastatic Pathologic Fractures, Short Term Results

Start date: January 1, 2022
Phase:
Study type: Observational

This is a single center prospective study to compare the short term results of prosthesis, nail and plate-screw surgeries for metastatic pathologic fractures.

NCT ID: NCT04842266 Recruiting - Trauma Clinical Trials

IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures

Start date: November 18, 2021
Phase:
Study type: Observational

The aim of this project is to assess the effectiveness of the IlluminOss pelvic implants in patients with pelvic metastatic disease presenting with pain, risk of pathologic fracture, non-displaced or minimally displaced pathologic fracture of the pelvis, and geriatric patients with pelvic fragility fractures. Results from this study will be used to confirm preliminary clinically and possibly statistically significant reductions in pain and improvements in function among these patients.

NCT ID: NCT00525057 Completed - Lymphoma Clinical Trials

Dalteparin in Preventing DVT in Participants With Cancer

Start date: July 7, 2006
Phase: N/A
Study type: Interventional

This trial studies how well dalteparin works in preventing deep vein thrombosis (DVT) (blood clots) in participants with cancer. Dalteparin is a blood thinner that can treat blood clots and may prevent them from forming.